These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9616283)

  • 1. High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study.
    Namouni F; Doz F; Tanguy ML; Quintana E; Michon J; Pacquement H; Bouffet E; Gentet JC; Plantaz D; Lutz P; Vannier JP; Validire P; Neuenschwander S; Desjardins L; Zucker JM
    Eur J Cancer; 1997 Dec; 33(14):2368-75. PubMed ID: 9616283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma.
    Dunkel IJ; Chan HS; Jubran R; Chantada GL; Goldman S; Chintagumpala M; Khakoo Y; Abramson DH
    Pediatr Blood Cancer; 2010 Jul; 55(1):149-52. PubMed ID: 20486181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
    Pérez V; Sampor C; Rey G; Parareda-Salles A; Kopp K; Dabezies AP; Dufort G; Zelter M; López JP; Urbieta M; Alcalde-Ruiz E; Catala-Mora J; Suñol M; Ossandon D; Fandiño AC; Croxatto JO; de Dávila MTG; Reaman G; Ravindranath Y; Chantada GL
    JAMA Ophthalmol; 2018 Jul; 136(7):747-752. PubMed ID: 29799944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.
    Dunkel IJ; Khakoo Y; Kernan NA; Gershon T; Gilheeney S; Lyden DC; Wolden SL; Orjuela M; Gardner SL; Abramson DH
    Pediatr Blood Cancer; 2010 Jul; 55(1):55-9. PubMed ID: 20486171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma CSF metastasis cured by multimodality chemotherapy without radiation.
    Dimaras H; Héon E; Budning A; Doyle JJ; Halliday W; Gallie BL; Chan HS
    Ophthalmic Genet; 2009 Sep; 30(3):121-6. PubMed ID: 19941416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
    Chawla B; Hasan F; Seth R; Pathy S; Pattebahadur R; Sharma S; Upadhyaya A; Azad R
    Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results.
    Levy C; Doz F; Quintana E; Pacquement H; Michon J; Schlienger P; Validire P; Asselain B; Desjardins L; Zucker JM
    Br J Ophthalmol; 1998 Oct; 82(10):1154-8. PubMed ID: 9924303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer.
    deMagalhaes-Silverman M; Rybka WB; Lembersky B; Bloom EJ; Lister J; Pincus SM; Voloshin M; Wilson J; Ball ED
    Am J Clin Oncol; 1996 Apr; 19(2):169-73. PubMed ID: 8610643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study.
    Pein F; Michon J; Valteau-Couanet D; Quintana E; Frappaz D; Vannier JP; Philip T; Bergeron C; Baranzelli MC; Thyss A; Stephan JL; Boutard P; Gentet JC; Zucker JM; Tournade MF; Hartmann O
    J Clin Oncol; 1998 Oct; 16(10):3295-301. PubMed ID: 9779704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-escalation study of carboplatin/cyclophosphamide/etoposide along with autologous bone marrow or peripheral blood stem cell rescue.
    Shea TC; Storniolo AM; Mason JR; Newton B; Mullen M; Taetle R; Green MR
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):139-44. PubMed ID: 1411625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma.
    Kremens B; Wieland R; Reinhard H; Neubert D; Beck JD; Klingebiel T; Bornfeld N; Havers W
    Bone Marrow Transplant; 2003 Feb; 31(4):281-4. PubMed ID: 12621463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
    Grodman H; Wolfe L; Kretschmar C
    Pediatr Blood Cancer; 2009 Jul; 53(1):33-6. PubMed ID: 19326417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a prospective study for the treatment of unilateral retinoblastoma.
    Chantada GL; Fandiño AC; Guitter MR; Raslawski EC; Dominguez JL; Manzitti J; de Dávila MT; Zubizarreta P; Scopinaro M
    Pediatr Blood Cancer; 2010 Jul; 55(1):60-6. PubMed ID: 20486172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival and engraftment.
    Klumpp TR; Goldberg SL; Magdalinski AJ; Mangan KF
    Bone Marrow Transplant; 1997 Aug; 20(4):273-81. PubMed ID: 9285541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
    Dunkel IJ; Jubran RF; Gururangan S; Chantada GL; Finlay JL; Goldman S; Khakoo Y; O'Brien JM; Orjuela M; Rodriguez-Galindo C; Souweidane MM; Abramson DH
    Pediatr Blood Cancer; 2010 Mar; 54(3):384-7. PubMed ID: 19908299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
    Kremens B; Gruhn B; Klingebiel T; Hasan C; Laws HJ; Koscielniak E; Hero B; Selle B; Niemeyer C; Finckenstein FG; Schulz A; Wawer A; Zintl F; Graf N
    Bone Marrow Transplant; 2002 Dec; 30(12):893-8. PubMed ID: 12476282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
    Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
    Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
    Kleiner S; Kirsch A; Schwaner I; Kingreen D; Schwella N; Huhn D; Siegert W
    Bone Marrow Transplant; 1997 Dec; 20(11):953-9. PubMed ID: 9422474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
    Heath JA; Broxson EH; Dole MG; Filippa DA; George D; Lyden D; Dunkel IJ
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):160-3. PubMed ID: 11998794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.